Your browser doesn't support javascript.
loading
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.
Nakken, Sigrid; Eikrem, Øystein; Marti, Hans-Peter; Beisland, Christian; Bostad, Leif; Scherer, Andreas; Flatberg, Arnar; Beisvag, Vidar; Skandalou, Eleni; Furriol, Jessica; Strauss, Philipp.
Affiliation
  • Nakken S; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
  • Eikrem Ø; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
  • Marti HP; Department of Medicine, Haukeland University Hospital, 5021, Bergen, Norway.
  • Beisland C; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
  • Bostad L; Department of Medicine, Haukeland University Hospital, 5021, Bergen, Norway.
  • Scherer A; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
  • Flatberg A; Department of Urology, Haukeland University Hospital, 5021, Bergen, Norway.
  • Beisvag V; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
  • Skandalou E; Department of Pathology, Haukeland University Hospital, 5021, Bergen, Norway.
  • Furriol J; Spheromics, 81100, Kontiolahti, Finland.
  • Strauss P; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014, Helsinki, Finland.
Cancer Cell Int ; 21(1): 690, 2021 Dec 20.
Article in En | MEDLINE | ID: mdl-34930263
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Cell Int Year: 2021 Type: Article Affiliation country: Norway
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Cell Int Year: 2021 Type: Article Affiliation country: Norway